For this reason, we phenotypically characterized the kinetics of the systemic response based on the clinical signs (MSS system) and the plasma IL-6 levels, which is a reliable well-established biomarker of systemic inflammation and sepsis morbidity (Remick et al., 2002; Shapiro et al., 2010; Zhang et al., 2013). This evidence concerns the gene IL6 and Sepsis.